Cleared Traditional

K220331 - 091 Balloon Guide Catheter

K220331 is an FDA 510(k) clearance for 091 Balloon Guide Catheter, manufactured by Inneuroco, Inc.. The device is a Class 2 Neurology device with product code DQY cleared through the Traditional 510(k) pathway after a 175-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
175d
Days
Class 2
Risk

K220331 is an FDA 510(k) clearance for the 091 Balloon Guide Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Inneuroco, Inc. (Pembroke Pines, US). The FDA issued a Cleared decision on July 29, 2022 after a review of 175 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Inneuroco, Inc. devices

FDA 510(k) Submission Details - K220331

510(k) Number K220331 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2022
Decision Date July 29, 2022
Days to Decision 175 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
27d slower than avg
Panel avg: 148d · This submission: 175d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 621
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K220331.
Sublime Microcatheter
K221886 · Surmodics,Inc. · Oct 2022
SOFIA 88 Catheter
K214024 · MicroVention, Inc. · Sep 2022
GuideLiner Coast, 5.5F (5270)
K220647 · Vascular Solutions, LLC · Aug 2022
Selectra Lead Implantation System
K222037 · Biotronik, Inc. · Jul 2022
Artix Ballon Guiding Sheath
K221846 · Inari Medical · Jul 2022
CPS AIM Universal II Slittable Inner Catheter
K221750 · Abbott Medical · Jun 2022